Regarding another non‐SARS‐CoV‐2‐targeting blood‐derived product, the Surviving Sepsis Campaign (SSC) suggested the use of albumin combined with large volumes of crystalloids over the use of standalone crystalloids for adult patients with septic shock or sepsis.47 The gene discussed is ALB; the disease is Sepsis.